Protgen Ltd
Clinical trials sponsored by Protgen Ltd, explained in plain language.
-
New drug shows promise for liver cirrhosis fluid retention
Disease control CompletedThis early-stage study tested a new medicine called r-HSA in 36 adults with liver cirrhosis and ascites (fluid buildup in the belly). The goal was to check if the drug is safe and how the body processes it. Participants received one of three doses of r-HSA or an active comparison…
Phase: PHASE1 • Sponsor: Protgen Ltd • Aim: Disease control
Last updated Apr 24, 2026 16:19 UTC
-
Lab-Grown protein tested to help livers in crisis
Disease control CompletedThis study tested whether a lab-made version of a blood protein (recombinant human serum albumin) works as well as the standard version from human donors for people with advanced liver cirrhosis and fluid buildup in the abdomen (ascites). It involved 92 adult patients who receive…
Phase: PHASE2, PHASE3 • Sponsor: Protgen Ltd • Aim: Disease control
Last updated Apr 13, 2026 20:23 UTC
-
Lab-Grown protein tested to drain swollen bellies in liver patients
Disease control CompletedThis completed study tested whether a lab-made version of a blood protein (recombinant human serum albumin) works as well as the standard version from human donors for patients with liver cirrhosis and fluid buildup in the abdomen (ascites). It involved 390 adults and directly co…
Phase: PHASE2, PHASE3 • Sponsor: Protgen Ltd • Aim: Disease control
Last updated Apr 13, 2026 20:23 UTC
-
Lab-Made albumin passes first safety check in healthy volunteers
Knowledge-focused CompletedThis early-stage study tested a lab-made version of human serum albumin in 48 healthy adults to see if it is safe and how the body processes it. Participants received a single dose at one of four levels, with some getting a placebo. The goal was to check for side effects and meas…
Phase: PHASE1 • Sponsor: Protgen Ltd • Aim: Knowledge-focused
Last updated Apr 26, 2026 20:02 UTC